Oribiotech Ltd., Philadelphia

https://www.oribiotech.com

Ori is a London-and New Jersey-based manufacturing technology company pioneering flexible process discovery with seamless translation and scalable commercialization of cell and gene therapies. Ori has developed a proprietary, full stack manufacturing platform that closes, automates and standardizes CGT manufacturing allowing therapeutics developers to develop and bring their products to market at commercial scale. The promise of the innovative Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining proprietary hardware, software, data and analytics. Ori was founded in 2015 by Dr. Farlan Veraitch (UCL) and has brought together a seasoned Board and management team with over 200 years of combined pharmaceutical, CGT and venture building experience including CEO Jason C. Foster (Indivior), CBO Jason Jones (Miltenyi), CDOO Kevin Gordon (Tmunity), CTO Stuart Milne (Cytiva), VP Tom Heathman (Minaris), VP David Smith (Minaris), VP Lee Unroe (Indivior), Chris Mason (AVROBIO), Paul Meister (ThermoFisher) and Annalisa Jenkins (Dimension Therapeutics) alongside expert advisers like Bruce Levine, Anthony Davies, and Robert Preti. *

	Start	2025-01-09 existent
	Group	Ori Biotech (Oribiotech) (Group)
	Industry	cell therapy manufacturing/processing technology
	Industry 2	gene therapy manufacturing/processing technology
	Person	Foster, Jason C. (Oribiotech 202001– CEO)

	Region	Philadelphia, PA
	Country	United States (USA)
	Street	3675 Market Street CIC
	City	19204 Philadelphia, PA
		Address record changed: 2025-01-11

Basic data	Employees	n. a.

		* Document for »About Section«: Oribiotech Ltd.. (1/18/22). "Press Release: Ori Biotech Raises over $100 Million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform". London.

		Record changed: 2025-01-11